載入...
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-small Cell Lung Cancer (NSCLC)
IMPORTANCE: Early phase trials with monoclonal antibodies targeting PD-1/PD-L1 have demonstrated durable clinical responses in patients with NSCLC, however, current assays for the prognostic/predictive role of tumor PD-L1 expression are not standardized with respect to either quantity or distributio...
Na minha lista:
| 發表在: | JAMA Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941982/ https://ncbi.nlm.nih.gov/pubmed/26562159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2015.3638 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|